Skip to main content
Clinical Trials/CTRI/2022/12/048343
CTRI/2022/12/048343Not yet recruitingPhase 3

Comparison of effects of dexmedetomidine-ketamine and midazolam-ketamine combination in transurethral procedures.

Sangey Doma Tamang0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patients of ASA physical status 1 and 2. Patients able to comprehend and willing to participate. Patients scheduled for elective transurethral procedures.

Exclusion Criteria

  • Patientâ??s refusal to participate. Patients with known contraindication or sensitivity to study drugs. Patients on concomitant analgesic, sedative medication, or chronic use of an α-agonist. Patients with chronic renal insufficiency, liver dysfunction, psychiatric or emotional disorders, respiratory disorders, sleep apnea, second or third degree heart block.

Investigators

Sponsor
Sangey Doma Tamang

Similar Trials